Conducteurs
Contrôlez votre état avant une visite médicale, une récupération de permis ou avant de reprendre le volant.
Urine Test 13 Drugs Drugdiag® 13T
Laboratoire Toda Pharma
Usual price
$33.00 USD
Usual price
Promotional price
$33.00 USD
Shipping costs calculated at checkout.
Livraison express disponible
Le lendemain avant 13h en point relais
Option proposée au paiement selon éligibilité transporteur et heure de commande.
Choisir la quantité
1 unité
Prix standard
$33.00
$27.50 HT
Ajouter au panier
Pack de 5
$165.00
$137.50 HT
Ajouter au panier
Pack de 10
Économisez $33.00
$297.00
$247.50 HT
Ajouter au panier
Pack de 25
Économisez $123.75
$701.25
$584.38 HT
Ajouter au panier
Entreprises & Collectivités
Offre sur mesure
Unable to load the pickup service availability
🎧 Comprendre les durées de détection
Écoutez notre épisode explicatif pour mieux interpréter les délais selon la substance, le type de test et le contexte.
Drugdiag® 13T 13-Drug Urine Test
The Drugdiag® T13 urine test is a multi-drug screening device designed to simultaneously detect 13 substance families in urine. It is intended for healthcare professionals, businesses, prevention organizations, and individuals seeking a quick, reliable, and easy-to-interpret control.
This test does not detect synthetic drugs such as 3-MMC, 4-MMC, 2-MMC, PTC / Buddha Blue, MDPV, or α-PVP. The Drugdiag® T13 specifically targets the following families: THC, AMP, BAR, BZO, BUP, COC, MDMA, MET, MTD, MOP, TCA, TML, and FYL.
🧪 Substances detected by the Drugdiag® T13:
- THC: cannabis / THC-COOH.
- AMP: amphetamines.
- BAR: barbiturates.
- BZO: benzodiazepines.
- BUP: buprenorphine.
- COC: cocaine.
- MDMA: ecstasy.
- MET: methamphetamines.
- MTD: methadone.
- MOP: opiates / morphine.
- TCA: tricyclic antidepressants.
- TML: tramadol.
- FYL: fentanyl.
Why choose the Drugdiag® T13 urine test? Why choose the Drugdiag® T13 urine test? Broad screening in a single analysis…
Why choose the Drugdiag® T13 urine test?
Broad screening in a single analysis
The Drugdiag® T13 allows screening of 13 substance families with a single device. It is especially useful when a comprehensive urine screening is needed, notably in professional, medical, preventive, or personal contexts.
Quick and simple reading
The test is designed for practical use: urine sampling, contact with the sample, then visual reading of the result within minutes according to the instructions.
Professional solution
Suitable for businesses, healthcare professionals, prevention organizations, and individuals, this test offers a reliable solution to quickly identify the possible presence of commonly screened substances.
Key features of the Drugdiag® T13 Key features of the Drugdiag® T13 13 families detected: THC, AMP, BAR, BZO, BUP,…
Key features of the Drugdiag® T13
- 13 families detected: THC, AMP, BAR, BZO, BUP, COC, MDMA, MET, MTD, MOP, TCA, TML, and FYL.
- Urine format: suitable for detecting many metabolites eliminated in urine.
- Rapid result: visual reading in a few minutes according to the usage protocol.
- Versatile use: companies, health, prevention, communities, specialized structures, and self-testing.
- French manufacturing: device from the Drugdiag® range by Toda Pharma laboratory.
- Professional quality: in vitro diagnostic medical device with CE marking.
Table of the 13 detected families Table of the 13 detected families The Drugdiag® T13 should not be confused with a…
Table of the 13 detected families
The Drugdiag® T13 should not be confused with a test specific to new synthetic drugs. It detects the following substance families:
| Code | Detected family | Examples / use of screening |
|---|---|---|
| THC | Cannabis | Detection of THC-COOH, the main cannabis metabolite in urine. |
| AMP | Amphetamines | Screening for amphetamines and related substances according to test thresholds. |
| BAR | Barbiturates | Detection of barbiturates, sedative substances now less common but still monitored. |
| BZO | Benzodiazepines | Family of anxiolytic, hypnotic, or sedative medications that can impair alertness. |
| BUP | Buprenorphine | Detection of buprenorphine, notably in opioid monitoring or control contexts. |
| COC | Cocaine | Screening for cocaine and its urinary metabolites. |
| MDMA | Ecstasy | Detection of MDMA, a stimulant substance frequently associated with party environments. |
| MET | Methamphetamines | Screening for methamphetamines according to device thresholds. |
| MTD | Methadone | Detection of methadone, notably in opioid monitoring or control contexts. |
| MOP | Opiates / morphine | Screening for natural and related opiates, depending on test performance. |
| TCA | Tricyclic antidepressants | Detection of TCAs, a family of medications that may be monitored in certain clinical contexts. |
| TML | Tramadol | Screening for tramadol, an opioid analgesic that can impair alertness and present risks of misuse. |
| FYL | Fentanyl | Detection of fentanyl, a powerful opioid requiring particular vigilance in prevention and health contexts. |
The detected families must always be verified with the product instructions and the thresholds indicated by the manufacturer. A rapid test provides a preliminary result; in case of doubt, a result must be confirmed by laboratory analysis.
⚠️ Important: this test does not detect specific synthetic drugs
The Drugdiag® T13 should not be presented as a screening test for synthetic cathinones or synthetic cannabinoids.
It does not specifically target substances such as 3-MMC, 4-MMC, 2-MMC, PTC / Buddha Blue, MDPV, or α-PVP.
To detect these substances, a test adapted to new psychoactive substances and synthetic drugs must be used.
When to use the Drugdiag® T13? When to use the Drugdiag® T13? Companies and prevention The test can be…
When to use the Drugdiag® T13?
Companies and prevention
The test can be integrated into a risk prevention approach in companies, especially for security positions or sensitive environments, in compliance with the applicable legal framework, internal regulations, and confidentiality of results.
Healthcare professionals
It is a rapid screening tool to guide care, monitoring, or a request for biological confirmation when the clinical context requires it.
Individuals and self-testing
The Drugdiag® T13 can be used by individuals wishing to perform broad urinary self-testing, with a simple and quick result reading.
Screening, prevention, and chemical submission Screening, prevention, and chemical submission The Drugdiag® T13 can contribute to a…
Screening, prevention, and chemical submission
The Drugdiag® T13 can contribute to a broad prevention approach, especially when it is necessary to detect multiple families of substances such as benzodiazepines, opiates, tramadol, fentanyl, methadone, cocaine, amphetamines, or cannabis.
However, it does not allow for the detection of all substances that may be involved in a chemical submission situation. It does not replace medical care, filing a complaint, or specialized toxicological analysis performed by a laboratory.
Contents of the pouch Contents of the pouch The product is packaged to ensure simple and…
Contents of the pouch
The product is packaged to ensure simple and hygienic use:
- 1 Drugdiag® T13 urine test.
- 1 user manual according to the manufacturer’s packaging.
- Result readable directly on the device after performing the test.
Clinical expertise & device quality Clinical expertise & device quality Rapid screening technology The Drugdiag®…
Clinical expertise & device quality
Rapid screening technology
The Drugdiag® T13 is based on immunochromatographic technology allowing rapid detection of the possible presence of several substance families in a urine sample.
In vitro diagnostic medical device
This test is an in vitro diagnostic medical device. It bears the CE marking under the regulations applicable to diagnostic devices.
Made in France and Toda Pharma quality
The Drugdiag® T13 belongs to the Drugdiag® range from the French laboratory Toda Pharma, a recognized player in rapid diagnostic testing. It meets professional quality standards adapted to screening, prevention, and health uses.
CE
In vitro diagnostic
Toda Pharma
Made in France
Professional use
Usage advice Usage advice Read the instructions carefully before use. Use a…
Usage advice
- Read the instructions carefully before use.
- Use a clean urine sample, under appropriate conditions.
- Respect the reading time indicated by the manufacturer.
- Do not interpret the result beyond the recommended time frame.
- In case of a positive, doubtful, or contested result, request confirmation in a laboratory.
A rapid urine test is a screening and guidance tool. It does not alone constitute definitive forensic evidence. For any medical, professional, or legal decision, confirmation by toxicological analysis may be necessary.
Une solution de dépistage adaptée à chaque usage
Une solution fiable, rapide et simple à intégrer dans une démarche de prévention, adaptée aux conducteurs, entreprises, forces de l’ordre, professionnels de santé et particuliers.
Entreprises
Renforcez la sécurité des équipes avec des outils adaptés aux postes à risques et aux procédures internes.
Forces de l’ordre
Utilisez un matériel professionnel éprouvé pour les missions de contrôle, de prévention et d’intervention terrain.
Particuliers
Levez le doute simplement, favorisez le dialogue et adoptez une démarche responsable d’auto-contrôle.
Expertise médicale & conformité
Développé par un laboratoire français, ce dispositif s’inscrit dans une démarche de prévention documentée, avec des exigences de qualité, de traçabilité et de fiabilité adaptées aux usages professionnels.
Laboratoire français
CE / ISO 13485
Arrêté 13 décembre 2016
Utilisé par les Armées Françaises